Cargando…
Targeting Inflammation in Emerging Therapies for Genetic Retinal Disease
Genetic retinal diseases such as age-related macular degeneration and monogenic diseases such as retinitis pigmentosa account for some of the commonest causes of blindness in the developed world. Diverse genetic abnormalities and environmental causes have been implicated in triggering multiple patho...
Autores principales: | Viringipurampeer, Ishaq A., Bashar, Abu E., Gregory-Evans, Cheryl Y., Moritz, Orson L., Gregory-Evans, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594980/ https://www.ncbi.nlm.nih.gov/pubmed/23509666 http://dx.doi.org/10.1155/2013/581751 |
Ejemplares similares
-
An ex vivo gene therapy approach in X-linked retinoschisis
por: Bashar, Abu E., et al.
Publicado: (2016) -
Ex vivo gene therapy using intravitreal injection of GDNF-secreting mouse embryonic stem cells in a rat model of retinal degeneration
por: Gregory-Evans, Kevin, et al.
Publicado: (2009) -
RNA-based therapies in animal models of Leber congenital amaurosis causing blindness
por: Wang, Xia, et al.
Publicado: (2020) -
Gene-specific differential response to anti-apoptotic therapies in zebrafish models of ocular coloboma
por: Gregory-Evans, Cheryl Y., et al.
Publicado: (2011) -
Efficacy of Postnatal In Vivo Nonsense Suppression Therapy in a Pax6 Mouse Model of Aniridia
por: Wang, Xia, et al.
Publicado: (2017)